GX 03
Alternative Names: GX-03Latest Information Update: 07 Aug 2024
At a glance
- Originator Turn Therapeutics
- Class Antifungals; Antineoplastics; Antiseptics; Antivirals; Eye disorder therapies; Quaternary ammonium compounds; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II COVID 2019 infections
- Preclinical Basal cell cancer; Eczema
- No development reported Onychomycosis